Pfizer starts reopening of tornado-damaged Rocky Mount plant, eyes Q4 for full operations
Pfizer has begun to reopen its tornado-impacted facility in Rocky Mount, with the company forecasting it would be fully operational by the fourth quarter.
On July 19, Pfizer halted production and manufacturing in its 1.4 million-square-foot facility in North Carolina as it was hit by an EF-3 tornado, primarily damaging the site warehouse.
Because the site manufactures nearly a quarter of sterile injectables used in US hospitals, there were concerns over shortages. Pfizer subsequently placed a dozen products on emergency order to accommodate distribution issues.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.